DELSTRIGO

Identification of Delstrigo

No description

Google image searchProduct monograph

Active ingredients

doravirine, 100 MG

lamivudine, 300 MG

tenofovir disoproxil fumarate, 300 MG

DIN: 02482592

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: MERCK CANADA INC

Date: 10-DEC-2018

ATC:

Reference brand drug: Delstrigo

Search on Google

Merck Canada Inc

Go to Merck website to see drug product details. Sometimes you can find delstrigo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.